| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
1116 |
| issn |
0114-5916
1179-1942 |
| issueIdentifier |
11 |
| pageRange |
1115-1116 |
| publicationName |
Drug Safety |
| startingPage |
1115 |
| bibliographicCitation |
Harrison-Woolrych M. Patient reporting encouraged during monitoring of dapoxetine in New Zealand. Drug Saf. 2011 Nov 01;34(11):1115–6. doi: 10.2165/11596010-000000000-00000. PMID: 21981438. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6529e63536bb1bbe1896cb97da1ebd6e |
| date |
2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.2165/11596010-000000000-00000
https://pubmed.ncbi.nlm.nih.gov/21981438 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0114-5916
https://portal.issn.org/resource/ISSN/1179-1942
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1481 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Patient Reporting Encouraged during Monitoring of Dapoxetine in New Zealand |
| discusses |
http://id.nlm.nih.gov/mesh/M0002392
http://id.nlm.nih.gov/mesh/M0215302
http://id.nlm.nih.gov/mesh/M0014459
http://id.nlm.nih.gov/mesh/M0026372 |